TOPICAL TOLERABILITY OF CALCITONIN NASAL PREPARATION, ITS EXCIPIENTS AND SODIUM TAUROCHOLATE STUDIED BY SEM AND MUCOCILIARY TRANSPORT VELOCITY

被引:3
作者
BRAGA, PC
PIATTI, G
BERNINI, A
DALSASSO, M
机构
[1] Department of Pharmacology, Chemotherapy and Toxicology, School of Medicine, University of Milan, Milano, 20129, Via Vanvitelli
来源
DRUG INVESTIGATION | 1992年 / 4卷 / 01期
关键词
D O I
10.1007/BF03258377
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In addition to the active drugs, intranasal preparations contain various excipients and preservatives to stabilise the formulation and prevent the growth of contaminating microorganisms during repeated use. This study assessed the topical tolerability of 1-7 Asu eel and salmon calcitonin, the excipients ammonium glycyrrhizinate, methyl and propyl p-hydroxybenzoate and benzalkonium chloride, and sodium taurocholate, which is used in other preparations to promote absorption. The ex vivo frog plate preparation was used to measure mucociliary transport velocity (MTV) as an index of their effects. In addition, scanning electron microscopy (SEM) was used to study the morphology of the mucosal surface of the palate before and after contact with the test substances. Frog Ringer's solution, 1-7 Asu eel and salmon calcitonin did not significantly change MTV, confirming good tolerability by ciliated epithelium. The same was true for 0.5 and 2% ammonium glycyrrhizinate and 0.01% benzalkonium chloride, while p-hydroxybenzoates produced a small though significant reduction in MTV. Sodium taurocholate, however, led to a significant reduction in MTV for the palate with and without muscus. SEM studies confirmed the results, clearly identifying the damage to epithelial ciliated cells produced by sodium taurocholate.
引用
收藏
页码:40 / 46
页数:7
相关论文
共 7 条
[1]  
Anderson T.F., Techniques for the preservation of 3 dimensional structures in preparing specimens for the electron microscope, Transactions of the New York Academy of Sciences, 13, pp. 130-134, (1951)
[2]  
Batts A.H., Marriot C., Martin G.P., Wood C.F., Bond S.W., The effect of some preservatives used in nasal preparations on the mucus and ciliary components of mucociliary clearance, Journal of Pharmacy and Pharmacology, 42, pp. 145-151, (1990)
[3]  
Braga P.C., Macrophotographic evidence of the activity of sobrerol on mucociliary transport in the frog’s palate, Clinical Trials Journal, 18, pp. 30-38, (1981)
[4]  
Braga P.C., Allegra L., Rampoldi C., Beghi G., Ornaghi A., Et al., Topical tolerability of salmon calcitonin assessed by mucociliary transport velocity investigation, Arzneimittel-Forschung, 40, pp. 930-941, (1990)
[5]  
Buclin T., Raudin J.P., Jaquet A.F., Azria M., Attinger M., Et al., The effect of rectal and nasal administration of salmon calcitonin in normal subjects, Calcified Tissue International, 41, pp. 252-258, (1987)
[6]  
Pontiroli A.E., Calderara A., Pozza G., Intranasal drug delivery. Potential advantages and limitations from a clinical pharmacokinetic perspective, Clinical Pharmacokinetics, 17, pp. 299-307, (1989)
[7]  
Puchelle E., Girard F., Zahm J.M., Rheologie des secretions bronchiques et transport muco-ciliaire, Bulletin Europeen de Physiopathologie Respiratoire, 12, pp. 771-775, (1970)